-
Legendary Country Music Talent at #ACountryThing Helps Raise $1 Million and Celebrates Tremendous Parkinson’s Research Momentum
April 18, 2025
… $41 million raised by the crew last summer while rowing from Monterey, California to Kauai, Hawaii — all to advance … raised over $1 million, with 100 percent of proceeds from the evening going directly to speed the Foundation’s … and Sonny Whelan. Check out these top highlights from #ACountryThing. Photo Gallery Chris Stapleton …
-
Making Sense of Health Care Reform in Washington
July 20, 2017
… more about what's been happening, where Congress may go from here and how you can continue to play a role in this … home states for a summer recess. (The House will break from July 31 to September 4 and the Senate from August 14 to September 4.) Right now, it looks like …
-
Lead Major Gifts Director (Midwest and Mountain Territories)
… and prospects with a focus on raising $4M to $10M annually from high five-figure to low seven-figure contributions. … and prospects with a focus on raising $4M to $10M annually from high five-figure to low seven-figure contributions. … Proven track record of strategic relationship building, from cultivation through solicitation and stewardship …
-
Peroxisome-Proliferator Activated Receptor gamma as a Target for Anti-Dyskinesia Pharmacotherapy
… model of Parkinson’s disease (PD). Preliminary data from our laboratory suggest that administration of … to control and ameliorate motor abnormalities resulting from long-term L-DOPA treatment. Presentations & … for publication, in press, or published) that resulted from the work made possible by this award. 1) Martinez AA, …
-
Genetic-epidemiological Confirmation of Top Hits of GWAS of Parkinson Disease: A Large Multi-center Collaborative Study
… diseases. Anticipated Outcome : Our proposed study, apart from validating genetic effects, will for the first time delineate the role of non-genetic component from selected variants. Defining the role of genetic … consortium. A total of 21 sites representing 19 countries from 4 continents agreed to contribute DNA samples and …
-
Neuroprotective efficacy of RAB3B in pre-clinical models of alpha-synucleinopathy
… shown can enhance function and prevent dopamine neurons from dying in a pre-clinical model of Parkinson’s disease … to test the capacity of RAB3B to protect dopamine neurons from degeneration in our recently developed pre-clinical … & Side Effects and do not prevent the dopamine neurons from dying. Our AAV-alpha-synucleinopathy model allows us to …